Hot Stocks to Watch GERN, CYTX, Friday 09-30-2011
GERN - Geron Corporation, a biopharmaceutical company, develops biopharmaceuticals for the treatment of cancer and chronic degenerative diseases, including spinal cord injury, heart failure, and diabetes. It develops a range of anti-cancer therapies based on telomerase inhibitors and telomerase therapeutic vaccines; and diagnostics based on telomerase detection as a marker for cancer diagnosis, prognosis, patient monitoring, and screening. Very Attractive, Bouncing Back, Just appointed a New CEO.
CYTX - Cytori Therapeutics is engaged in the development of medical products to enable the practice of regenerative medicine. Regenerative medicines focus on repairing or restoring lost or damaged tissue and cell function. Its principal products include the Celution family of products. The Celution family of products consists of a central device, a related single-use consumable used for each patient procedure, proprietary enzyme reagents, and related instrumentation. Attractive, Bouncing Back from 52WK Lows.
You are missing the Premium Alerts! Sign-up, Get Alerts that MakeMoney!®
we get compensated by the companies we feature. Always Read the full Disclosure/Disclaimer. Thanks